“The Impact of CYP2C9 Rs1057910 and rs1799853 Polymorphism on the Effectiveness of Glibenclamide in T2DM Iraqi Patients”. Genetics and Molecular Research 25, no. 1 (January 5, 2026): 1–25. Accessed January 29, 2026. https://geneticsmr.com/index.php/gmr/article/view/205.